Lysophosphatidylinositol signalling: New wine from an old bottle

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1821, Issue 4, 2012, Pages 694-705

  Piñeiro, Roberto ^a   Falasca, Marco ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

GPCR; GPR55; Lysophosphatidylinositol; Lysophospolipid

Indexed keywords

G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 55; LYSOPHOSPHATIDYLINOSITOL; LYSOPHOSPHOLIPID; PHOSPHOLIPASE A2; UNCLASSIFIED DRUG;

CARCINOGENESIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; CELL TYPE; PRIORITY JOURNAL; REVIEW;

ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; LYSOPHOSPHOLIPIDS; MODELS, BIOLOGICAL; NEOPLASMS; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84858308892     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2012.01.009     Document Type: Review

References (153)

1. E. Birgbauer, and J. Chun New developments in the biological functions of lysophospholipids Cell. Mol. Life Sci. 63 2006 2695 2701 (Pubitemid 44913311)
2. J.A. Lundbaek, and O.S. Andersen Lysophospholipids modulate channel function by altering the mechanical properties of lipid bilayers J. Gen. Physiol. 104 1994 645 673 (Pubitemid 24328596)
3. H.U. Weltzien Cytolytic and membrane-perturbing properties of lysophosphatidylcholine Biochim. Biophys. Acta 559 1979 259 287
4. L.A. van Meeteren, and W.H. Moolenaar Regulation and biological activities of the autotaxin-LPA axis Prog. Lipid Res. 46 2007 145 160 (Pubitemid 46654231)
5. H. Fyrst, and J.D. Saba An update on sphingosine-1-phosphate and other sphingolipid mediators Nat. Chem. Biol. 6 2010 489 497
6. E.J. van Corven, A. Groenink, K. Jalink, T. Eichholtz, and W.H. Moolenaar Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins Cell 59 1989 45 54 (Pubitemid 19248557)
7. W.H. Moolenaar, W. Kruijer, B.C. Tilly, I. Verlaan, A.J. Bierman, and S.W. de Laat Growth factor-like action of phosphatidic acid Nature 323 1986 171 173 (Pubitemid 16024967)
8. D.W. Siegmann Stimulation of quiescent 3T3 cells by phosphatidic acid-containing liposomes Biochem. Biophys. Res. Commun. 145 1987 228 233 (Pubitemid 17088428)
9. C.L. Yu, M.H. Tsai, and D.W. Stacey Cellular ras activity and phospholipid metabolism Cell 52 1988 63 71 (Pubitemid 18054591)
10. H. Zhang, N.E. Buckley, K. Gibson, and S. Spiegel Sphingosine stimulates cellular proliferation via a protein kinase C-independent pathway J. Biol. Chem. 265 1990 76 81
11. H. Zhang, N.N. Desai, J.M. Murphey, and S. Spiegel Increases in phosphatidic acid levels accompany sphingosine-stimulated proliferation of quiescent Swiss 3T3 cells J. Biol. Chem. 265 1990 21309 21316 (Pubitemid 120014154)
12. T.K. Ghosh, J. Bian, and D.L. Gill Intracellular calcium release mediated by sphingosine derivatives generated in cells Science 248 1990 1653 1656
13. H. Zhang, N.N. Desai, A. Olivera, T. Seki, G. Brooker, and S. Spiegel Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation J. Cell Biol. 114 1991 155 167 (Pubitemid 21909788)
14. N.N. Desai, H. Zhang, A. Olivera, M.E. Mattie, and S. Spiegel Sphingosine-1-phosphate, a metabolite of sphingosine, increases phosphatidic acid levels by phospholipase D activation J. Biol. Chem. 267 1992 23122 23128
15. J. Wu, S. Spiegel, and T.W. Sturgill Sphingosine 1-phosphate rapidly activates the mitogen-activated protein kinase pathway by a G protein-dependent mechanism J. Biol. Chem. 270 1995 11484 11488
16. T. Eichholtz, K. Jalink, I. Fahrenfort, and W.H. Moolenaar The bioactive phospholipid lysophosphatidic acid is released from activated platelets Biochem. J. 291 Pt. 3 1993 677 680 (Pubitemid 23148436)
17. Y. Yatomi, F. Ruan, S. Hakomori, and Y. Igarashi Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets Blood 86 1995 193 202
18. M. Murph, and G.B. Mills Targeting the lipids LPA and S1P and their signalling pathways to inhibit tumour progression Expert Rev. Mol. Med. 9 2007 1 18 (Pubitemid 47617558)
19. R.L. van der Bend, J. Brunner, K. Jalink, E.J. van Corven, W.H. Moolenaar, and W.J. van Blitterswijk Identification of a putative membrane receptor for the bioactive phospholipid, lysophosphatidic acid EMBO J. 11 1992 2495 2501
20. F.R. Postma, K. Jalink, T. Hengeveld, and W.H. Moolenaar Sphingosine-1-phosphate rapidly induces Rho-dependent neurite retraction: action through a specific cell surface receptor EMBO J. 15 1996 2388 2392 (Pubitemid 26151178)
21. J.H. Hecht, J.A. Weiner, S.R. Post, and J. Chun Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex J. Cell Biol. 135 1996 1071 1083 (Pubitemid 26403779)
22. S. Spiegel, and S. Milstien Sphingosine-1-phosphate: an enigmatic signalling lipid Nat. Rev. Mol. Cell Biol. 4 2003 397 407 (Pubitemid 36565571)
23. S. Okudaira, H. Yukiura, and J. Aoki Biological roles of lysophosphatidic acid signaling through its production by autotaxin Biochimie 92 2010 698 706
24. B. Anliker, and J. Chun Lysophospholipid G protein-coupled receptors J. Biol. Chem. 279 2004 20555 20558 (Pubitemid 38656446)
25. I. Ishii, N. Fukushima, X. Ye, and J. Chun Lysophospholipid receptors: signaling and biology Annu. Rev. Biochem. 73 2004 321 354 (Pubitemid 39050372)
26. G. Tigyi Aiming drug discovery at lysophosphatidic acid targets Br. J. Pharmacol. 161 2010 241 270
27. H. Sharir, and M.E. Abood Pharmacological characterization of GPR55, a putative cannabinoid receptor Pharmacol. Ther. 126 2010 301 313
28. R.A. Ross The enigmatic pharmacology of GPR55 Trends Pharmacol. Sci. 30 2009 156 163
29. C.M. Henstridge, N.A. Balenga, J. Kargl, C. Andradas, A.J. Brown, A. Irving, C. Sanchez, and M. Waldhoer Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55 Mol. Endocrinol. 25 2011 1835 1848
30. S. Anavi-Goffer, G. Baillie, A.J. Irving, J. Gertsch, I.R. Greig, R.G. Pertwee, and R.A. Ross Modulation of L-alpha-lysophosphatidylinositol/GPR55 MAP kinase signalling by cannabinoids J. Biol. Chem. 287 2012 91 104
31. S.A. Metz Lysophosphatidylinositol, but not lysophosphatidic acid, stimulates insulin release. A possible role for phospholipase A2 but not de novo synthesis of lysophospholipid in pancreatic islet function Biochem. Biophys. Res. Commun. 138 1986 720 727 (Pubitemid 16013196)
32. S.A. Metz Putative roles for lysophospholipids as mediators and lipoxygenase-mediated metabolites of arachidonic acid as potentiators of stimulus-secretion coupling: dual mechanisms of p-hydroxymercuribenzoic acid-induced insulin release J. Pharmacol. Exp. Ther. 238 1986 819 832 (Pubitemid 16033215)
33. T. Alonso, R.O. Morgan, J.C. Marvizon, H. Zarbl, and E. Santos Malignant transformation by ras and other oncogenes produces common alterations in inositol phospholipid signaling pathways Proc. Natl. Acad. Sci. U. S. A. 85 1988 4271 4275
34. T. Alonso, and E. Santos Increased intracellular glycerophosphoinositol is a biochemical marker for transformation by membrane-associated and cytoplasmic oncogenes Biochem. Biophys. Res. Commun. 171 1990 14 19 (Pubitemid 20283163)
35. M. Falasca, A. Carvelli, C. Iurisci, R.G. Qiu, M.H. Symons, and D. Corda Fast receptor-induced formation of glycerophosphoinositol-4-phosphate, a putative novel intracellular messenger in the Ras pathway Mol. Biol. Cell 8 1997 443 453 (Pubitemid 27171294)
36. L. Iacovelli, M. Falasca, S. Valitutti, D. D'Arcangelo, and D. Corda Glycerophosphoinositol 4-phosphate, a putative endogenous inhibitor of adenylylcyclase J. Biol. Chem. 268 1993 20402 20407 (Pubitemid 23278950)
37. M. Falasca, and D. Corda Elevated levels and mitogenic activity of lysophosphatidylinositol in k-ras-transformed epithelial cells Eur. J. Biochem. 221 1994 383 389 (Pubitemid 24120583)
38. M. Falasca, M.G. Silletta, A. Carvelli, A.L. Di Francesco, A. Fusco, V. Ramakrishna, and D. Corda Signalling pathways involved in the mitogenic action of lysophosphatidylinositol Oncogene 10 1995 2113 2124
39. S. Oka, K. Nakajima, A. Yamashita, S. Kishimoto, and T. Sugiura Identification of GPR55 as a lysophosphatidylinositol receptor Biochem. Biophys. Res. Commun. 362 2007 928 934 (Pubitemid 47390663)
40. M.M. Billah, and E.G. Lapetina Formation of lysophosphatidylinositol in platelets stimulated with thrombin or ionophore A23187 J. Biol. Chem. 257 1982 5196 5200 (Pubitemid 12054840)
41. S.L. Hong, and D. Deykin The activation of phosphatidylinositol- hydrolyzing phospholipase A2 during prostaglandin synthesis in transformed mouse BALB/3T3 cells J. Biol. Chem. 256 1981 5215 5219 (Pubitemid 11057900)
42. R.F. Irvine, N. Hemington, and R.M. Dawson The hydrolysis of phosphatidylinositol by lysosomal enzymes of rat liver and brain Biochem. J. 176 1978 475 484 (Pubitemid 9061178)
43. T. Kobayashi, M. Kishimoto, and H. Okuyama Phospholipases involved in lysophosphatidylinositol metabolism in rat brain J. Lipid Mediat. Cell Signal. 14 1996 33 37 (Pubitemid 26343334)
44. H. Ueda, T. Kobayashi, M. Kishimoto, T. Tsutsumi, and H. Okuyama A possible pathway of phosphoinositide metabolism through EDTA-insensitive phospholipase A1 followed by lysophosphoinositide-specific phospholipase C in rat brain J. Neurochem. 61 1993 1874 1881 (Pubitemid 23317215)
45. H. Ueda, T. Kobayashi, M. Kishimoto, T. Tsutsumi, and H. Okuyama EDTA-insensitive deacylation of phosphatidylinositol in porcine platelet membranes Life Sci. 53 1993 629 634
46. A. Yamashita, T. Kumazawa, H. Koga, N. Suzuki, S. Oka, and T. Sugiura Generation of lysophosphatidylinositol by DDHD domain containing 1 (DDHD1): possible involvement of phospholipase D/phosphatidic acid in the activation of DDHD1 Biochim. Biophys. Acta 1801 2010 711 720
47. D.A. Six, and E.A. Dennis The expanding superfamily of phospholipase A(2) enzymes: classification and characterization Biochim. Biophys. Acta 1488 2000 1 19
48. S. Mariggio, J. Sebastia, B.M. Filippi, C. Iurisci, C. Volonte, S. Amadio, V. De Falco, M. Santoro, and D. Corda A novel pathway of cell growth regulation mediated by a PLA2alpha-derived phosphoinositide metabolite FASEB J. 20 2006 2567 2569
49. K. Singaravelu, C. Lohr, and J.W. Deitmer Regulation of store-operated calcium entry by calcium-independent phospholipase A2 in rat cerebellar astrocytes J. Neurosci. 26 2006 9579 9592 (Pubitemid 44396871)
50. K. Singaravelu, C. Lohr, and J.W. Deitmer Calcium-independent phospholipase A2 mediates store-operated calcium entry in rat cerebellar granule cells Cerebellum 7 2008 467 481
51. 2 +-independent phospholipase A2 and store-operated pathway in urocortin-induced vasodilatation of rat coronary artery Circ. Res. 101 2007 1194 1203 (Pubitemid 350146446)
52. O. Perisic, S. Fong, D.E. Lynch, M. Bycroft, and R.L. Williams Crystal structure of a calcium-phospholipid binding domain from cytosolic phospholipase A2 J. Biol. Chem. 273 1998 1596 1604 (Pubitemid 28133685)
53. M. Nakanishi, and D.W. Rosenberg Roles of cPLA2alpha and arachidonic acid in cancer Biochim. Biophys. Acta 1761 2006 1335 1343 (Pubitemid 44738711)
54. S. Murase, and H. Okuyama A membrane-bound phospholipase C with an apparent specificity for lysophosphatidylinositol in porcine platelets J. Biol. Chem. 260 1985 262 265 (Pubitemid 15164044)
55. T. Tsutsumi, T. Kobayashi, H. Ueda, E. Yamauchi, S. Watanabe, and H. Okuyama Lysophosphoinositide-specific phospholipase C in rat brain synaptic plasma membranes Neurochem. Res. 19 1994 399 406 (Pubitemid 24286606)
56. J. Aoki, A. Taira, Y. Takanezawa, Y. Kishi, K. Hama, T. Kishimoto, K. Mizuno, K. Saku, R. Taguchi, and H. Arai Serum lysophosphatidic acid is produced through diverse phospholipase pathways J. Biol. Chem. 277 2002 48737 48744 (Pubitemid 35470839)
57. M. Umezu-Goto, Y. Kishi, A. Taira, K. Hama, N. Dohmae, K. Takio, T. Yamori, G.B. Mills, K. Inoue, J. Aoki, and H. Arai Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production J. Cell Biol. 158 2002 227 233
58. F. Maingret, A.J. Patel, F. Lesage, M. Lazdunski, and E. Honore Lysophospholipids open the two-pore domain mechano-gated K(+) channels TREK-1 and TRAAK J. Biol. Chem. 275 2000 10128 10133 (Pubitemid 30202065)
59. A.J. Patel, M. Lazdunski, and E. Honore Lipid and mechano-gated 2P domain K(+) channels Curr. Opin. Cell Biol. 13 2001 422 428
60. + channels by polyunsaturated fatty acids and lysophospholipids J. Membr. Biol. 195 2003 147 164 (Pubitemid 37338957)
61. S. Oka, T. Toshida, K. Maruyama, K. Nakajima, A. Yamashita, and T. Sugiura 2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55 J. Biochem. 145 2009 13 20
62. G. Ben-Zeev, M. Telias, and I. Nussinovitch Lysophospholipids modulate voltage-gated calcium channel currents in pituitary cells; effects of lipid stress Cell Calcium 47 2010 514 524
63. A. Bondarenko, M. Waldeck-Weiermair, S. Naghdi, M. Poteser, R. Malli, and W.F. Graier GPR55-dependent and -independent ion signalling in response to lysophosphatidylinositol in endothelial cells Br. J. Pharmacol. 161 2010 308 320
64. 2 + transport Biochim. Biophys. Acta 982 1989 140 146 (Pubitemid 19159059)
65. M.T. Ma, J.F. Yeo, A.A. Farooqui, J. Zhang, P. Chen, and W.Y. Ong Differential effects of lysophospholipids on exocytosis in rat PC12 cells J. Neural Transm. 117 2010 301 308
66. + channels in endothelial cells Pflugers Arch. 461 2011 177 189
67. G. Hu, G. Ren, and Y. Shi The putative cannabinoid receptor GPR55 promotes cancer cell proliferation Oncogene 30 2011 139 141
68. R. Pineiro, T. Maffucci, and M. Falasca The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation Oncogene 30 2011 142 152
69. T. Soga, T. Ohishi, T. Matsui, T. Saito, M. Matsumoto, J. Takasaki, S. Matsumoto, M. Kamohara, H. Hiyama, S. Yoshida, K. Momose, Y. Ueda, H. Matsushime, M. Kobori, and K. Furuichi Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor Biochem. Biophys. Res. Commun. 326 2005 744 751 (Pubitemid 39655983)
70. M. Monet, D. Gkika, V. Lehen'kyi, A. Pourtier, F. Vanden Abeele, G. Bidaux, V. Juvin, F. Rassendren, S. Humez, and N. Prevarsakaya Lysophospholipids stimulate prostate cancer cell migration via TRPV2 channel activation Biochim. Biophys. Acta 1793 2009 528 539
71. R.A. Ross L-alpha-Lysophosphatidylinositol meets GPR55: a deadly relationship Trends Pharmacol. Sci. 32 2011 265 269
72. D.T. Baran, and A.M. Kelly Lysophosphatidylinositol: a potential mediator of 1,25-dihydroxyvitamin D-induced increments in hepatocyte cytosolic calcium Endocrinology 122 1988 930 934 (Pubitemid 18082049)
73. 2 +, phosphate and ATP at 37 degrees C Biochem. J. 224 1984 423 430 (Pubitemid 15168433)
74. P.E. Jensen Calphostin C-sensitive enhancements of force by lysophosphatidylinositol and diacylglycerols in mesenteric arteries from the rat Br. J. Pharmacol. 119 1996 15 22 (Pubitemid 26294517)
75. 2 + by lysophospholipids in rat islets of Langerhans Biochim. Biophys. Acta 968 1988 239 252 (Pubitemid 18078341)
76. 2 + transport in permeabilized pancreatic islets Cell Calcium 13 1992 193 202
77. 2 + signaling in endothelial cells via GPR55 by protection against CB1-receptor-triggered repression J. Cell Sci. 121 2008 1704 1717 (Pubitemid 351911827)
78. D.A. Andersson, M. Nash, and S. Bevan Modulation of the cold-activated channel TRPM8 by lysophospholipids and polyunsaturated fatty acids J. Neurosci. 27 2007 3347 3355 (Pubitemid 46474120)
79. 2 +-independent phospholipase A2-dependent gating of TRPM8 by lysophospholipids J. Biol. Chem. 281 2006 40174 40182 (Pubitemid 46041822)
80. J.E. Lauckner, J.B. Jensen, H.Y. Chen, H.C. Lu, B. Hille, and K. Mackie GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current Proc. Natl. Acad. Sci. U. S. A. 105 2008 2699 2704 (Pubitemid 351520576)
81. M. Raftopoulou, and A. Hall Cell migration: Rho GTPases lead the way Dev. Biol. 265 2004 23 32 (Pubitemid 38018819)
82. A.J. Ridley, M.A. Schwartz, K. Burridge, R.A. Firtel, M.H. Ginsberg, G. Borisy, J.T. Parsons, and A.R. Horwitz Cell migration: integrating signals from front to back Science 302 2003 1704 1709 (Pubitemid 37505725)
83. M.B. Wheeler, and G.E. Seidel Jr. Capacitation of bovine spermatozoa by lysophospholipids and trypsin Gamete Res. 22 1989 193 204 (Pubitemid 19195844)
84. M. Kohno, K. Yokokawa, K. Yasunari, M. Minami, H. Kano, T. Hanehira, and J. Yoshikawa Induction by lysophosphatidylcholine, a major phospholipid component of atherogenic lipoproteins, of human coronary artery smooth muscle cell migration Circulation 98 1998 353 359 (Pubitemid 28348058)
85. G. Murugesan, and P.L. Fox Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein J. Clin. Invest. 97 1996 2736 2744 (Pubitemid 26197088)
86. N. Kume, M.I. Cybulsky, and M.A. Gimbrone Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells J. Clin. Invest. 90 1992 1138 1144
87. N.A. Balenga, E. Aflaki, J. Kargl, W. Platzer, R. Schroder, S. Blattermann, E. Kostenis, A.J. Brown, A. Heinemann, and M. Waldhoer GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils Cell Res. 21 2011 1452 1469
88. L.A. Ford, A.J. Roelofs, S. Anavi-Goffer, L. Mowat, D.G. Simpson, A.J. Irving, M.J. Rogers, A.M. Rajnicek, and R.A. Ross A role for L-alpha-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells Br. J. Pharmacol. 160 2010 762 771
89. M. Falasca, C. Iurisci, A. Carvelli, A. Sacchetti, and D. Corda Release of the mitogen lysophosphatidylinositol from H-Ras-transformed fibroblasts; a possible mechanism of autocrine control of cell proliferation Oncogene 16 1998 2357 2365 (Pubitemid 28226883)
90. G.T. Snoek, C.P. Berrie, T.B. Geijtenbeek, H.A. van der Helm, J.A. Cadee, C. Iurisci, D. Corda, and K.W. Wirtz Overexpression of phosphatidylinositol transfer protein alpha in NIH3T3 cells activates a phospholipase A J. Biol. Chem. 274 1999 35393 35399 (Pubitemid 129512829)
91. W.S. Ho Angiogenesis: a new physiological role for N-arachidonoyl serine and GPR55? Br. J. Pharmacol. 160 2010 1580 1582
92. X. Zhang, Y. Maor, J.F. Wang, G. Kunos, and J.E. Groopman Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediator Br. J. Pharmacol. 160 2010 1583 1594
93. Y. Xiao, Y. Chen, A.W. Kennedy, J. Belinson, and Y. Xu Evaluation of plasma lysophospholipids for diagnostic significance using electrospray ionization mass spectrometry (ESI-MS) analyses Ann. N. Y. Acad. Sci. 905 2000 242 259 (Pubitemid 30255422)
94. Y.J. Xiao, B. Schwartz, M. Washington, A. Kennedy, K. Webster, J. Belinson, and Y. Xu Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids Anal. Biochem. 290 2001 302 313 (Pubitemid 32217542)
95. Y. Xu, Y.J. Xiao, L.M. Baudhuin, and B.M. Schwartz The role and clinical applications of bioactive lysolipids in ovarian cancer J. Soc. Gynecol. Investig. 8 2001 1 13
96. M. Murph, T. Tanaka, J. Pang, E. Felix, S. Liu, R. Trost, A.K. Godwin, R. Newman, and G. Mills Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis Methods Enzymol. 433 2007 1 25
97. R. Sutphen, Y. Xu, G.D. Wilbanks, J. Fiorica, E.C. Grendys Jr., J.P. LaPolla, H. Arango, M.S. Hoffman, M. Martino, K. Wakeley, D. Griffin, R.W. Blanco, A.B. Cantor, Y.J. Xiao, and J.P. Krischer Lysophospholipids are potential biomarkers of ovarian cancer Cancer Epidemiol. Biomarkers Prev. 13 2004 1185 1191 (Pubitemid 38917907)
98. C. Andradas, M.M. Caffarel, E. Perez-Gomez, M. Salazar, M. Lorente, G. Velasco, M. Guzman, and C. Sanchez The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK Oncogene 30 2011 245 252
99. R. Bicknell, and B.L. Vallee Angiogenin activates endothelial cell phospholipase C Proc. Natl. Acad. Sci. U. S. A. 85 1988 5961 5965
100. S.L. Hong, and D. Deykin Activation of phospholipases A2 and C in pig aortic endothelial cells synthesizing prostacyclin J. Biol. Chem. 257 1982 7151 7154 (Pubitemid 12035693)
101. S.L. Hong, N.J. McLaughlin, C.Y. Tzeng, and G. Patton Prostacyclin synthesis and deacylation of phospholipids in human endothelial cells: comparison of thrombin, histamine and ionophore A23187 Thromb. Res. 38 1985 1 10 (Pubitemid 15122219)
102. H. Kaya, G.M. Patton, and S.L. Hong Bradykinin-induced activation of phospholipase A2 is independent of the activation of polyphosphoinositide- hydrolyzing phospholipase C J. Biol. Chem. 264 1989 4972 4977 (Pubitemid 19092908)
103. T.L. Lambert, R.S. Kent, and A.R. Whorton Bradykinin stimulation of inositol polyphosphate production in porcine aortic endothelial cells J. Biol. Chem. 261 1986 15288 15293 (Pubitemid 17218109)
104. 2 +-independent pathways for release of arachidonic acid from phosphatidylinositol in endothelial cells J. Biol. Chem. 262 1987 13086 13092
105. 2 +-activated potassium channels is involved in lysophosphatidylcholine-induced monocyte adhesion to endothelial cells Atherosclerosis 190 2007 100 105 (Pubitemid 44908324)
106. C.R. Wolfram Kuhlmann, D. Wiebke Ludders, C.A. Schaefer, A. Kerstin Most, U. Backenkohler, T. Neumann, H. Tillmanns, and A. Erdogan Lysophosphatidylcholine-induced modulation of Ca(2 +)-activated K(+)channels contributes to ROS-dependent proliferation of cultured human endothelial cells J. Mol. Cell. Cardiol. 36 2004 675 682 (Pubitemid 38591600)
107. M. Fukao, Y. Hattori, M. Kanno, I. Sakuma, and A. Kitabatake Structural differences in the ability of lysophospholipids to inhibit endothelium-dependent hyperpolarization by acetylcholine in rat mesenteric arteries Biochem. Biophys. Res. Commun. 227 1996 479 483 (Pubitemid 26362829)
108. G. Godlewski, L. Offertaler, J.A. Wagner, and G. Kunos Receptors for acylethanolamides-GPR55 and GPR119 Prostaglandins Other Lipid Mediat. 89 2009 105 111
109. o-coupled receptor distinct from CB1, CB2 or EDG-1 Eur. J. Pharmacol. 489 2004 21 27 (Pubitemid 38520067)
110. C.R. Hiley, and S.S. Kaup GPR55 and the vascular receptors for cannabinoids Br. J. Pharmacol. 152 2007 559 561 (Pubitemid 350034976)
111. D.G. Johns, D.J. Behm, D.J. Walker, Z. Ao, E.M. Shapland, D.A. Daniels, M. Riddick, S. Dowell, P.C. Staton, P. Green, U. Shabon, W. Bao, N. Aiyar, T.L. Yue, A.J. Brown, A.D. Morrison, and S.A. Douglas The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects Br. J. Pharmacol. 152 2007 825 831 (Pubitemid 350034974)
112. P.C. Staton, J.P. Hatcher, D.J. Walker, A.D. Morrison, E.M. Shapland, J.P. Hughes, E. Chong, P.K. Mander, P.J. Green, A. Billinton, M. Fulleylove, H.C. Lancaster, J.C. Smith, L.T. Bailey, A. Wise, A.J. Brown, J.C. Richardson, and I.P. Chessell The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain Pain 139 2008 225 236
113. N. Blondeau, I. Lauritzen, C. Widmann, M. Lazdunski, and C. Heurteaux A potent protective role of lysophospholipids against global cerebral ischemia and glutamate excitotoxicity in neuronal cultures J. Cereb. Blood Flow Metab. 22 2002 821 834 (Pubitemid 34747599)
114. L.S. Whyte, E. Ryberg, N.A. Sims, S.A. Ridge, K. Mackie, P.J. Greasley, R.A. Ross, and M.J. Rogers The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo Proc. Natl. Acad. Sci. U. S. A. 106 2009 16511 16516
115. Wise, A., Brown, A.J., Identification of modulators of GPR55 activity, in: GlaxoSmithKline (Ed.), vol. WO01/86305, 2001.
116. E. Ryberg, N. Larsson, S. Sjogren, S. Hjorth, N.O. Hermansson, J. Leonova, T. Elebring, K. Nilsson, T. Drmota, and P.J. Greasley The orphan receptor GPR55 is a novel cannabinoid receptor Br. J. Pharmacol. 152 2007 1092 1101 (Pubitemid 350166046)
117. M. Sawzdargo, T. Nguyen, D.K. Lee, K.R. Lynch, R. Cheng, H.H. Heng, S.R. George, and B.F. O'Dowd Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain Brain Res. Mol. Brain Res. 64 1999 193 198 (Pubitemid 29052470)
118. S. Oka, S. Kimura, T. Toshida, R. Ota, A. Yamashita, and T. Sugiura Lysophosphatidylinositol induces rapid phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 lymphoblastoid cells J. Biochem. 147 2010 671 678
119. T. Okuno, and T. Yokomizo What is the natural ligand of GPR55? J. Biochem. 149 2011 495 497
120. E. Kotsikorou, D.L. Lynch, M.E. Abood, and P.H. Reggio Lipid bilayer molecular dynamics study of lipid-derived agonists of the putative cannabinoid receptor, GPR55 Chem. Phys. Lipids 164 2011 131 143
121. D.P. Hurst, A. Grossfield, D.L. Lynch, S. Feller, T.D. Romo, K. Gawrisch, M.C. Pitman, and P.H. Reggio A lipid pathway for ligand binding is necessary for a cannabinoid G protein-coupled receptor J. Biol. Chem. 285 2010 17954 17964
122. E. Kotsikorou, K.E. Madrigal, D.P. Hurst, H. Sharir, D.L. Lynch, S. Heynen-Genel, L.B. Milan, T.D. Chung, H.H. Seltzman, Y. Bai, M.G. Caron, L.S. Barak, M.E. Abood, and P.H. Reggio Identification of the Gpr55 agonist binding site using a novel set of high potency Gpr55 selective ligands Biochemistry 50 2011 5633 5647
123. D. Corda, C. Iurisci, and C.P. Berrie Biological activities and metabolism of the lysophosphoinositides and glycerophosphoinositols Biochim. Biophys. Acta 1582 2002 52 69 (Pubitemid 34634111)
124. 2 + signaling and NFAT activation FASEB J. 23 2009 183 193
125. K. Mackie Cannabinoid receptor homo- and heterodimerization Life Sci. 77 2005 1667 1673
126. T.H. Smith, L.J. Sim-Selley, and D.E. Selley Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery? Br. J. Pharmacol. 160 2010 454 466
127. S. An, T. Bleu, O.G. Hallmark, and E.J. Goetzl Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid J. Biol. Chem. 273 1998 7906 7910 (Pubitemid 28168837)
128. J. Radeff-Huang, T.M. Seasholtz, R.G. Matteo, and J.H. Brown G protein mediated signaling pathways in lysophospholipid induced cell proliferation and survival J. Cell. Biochem. 92 2004 949 966 (Pubitemid 44264244)
129. K. Bandoh, J. Aoki, H. Hosono, S. Kobayashi, T. Kobayashi, K. Murakami-Murofushi, M. Tsujimoto, H. Arai, and K. Inoue Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid J. Biol. Chem. 274 1999 27776 27785
130. J.I. Fells, R. Tsukahara, Y. Fujiwara, J. Liu, D.H. Perygin, D.A. Osborne, G. Tigyi, and A.L. Parrill Identification of non-lipid LPA3 antagonists by virtual screening Bioorg. Med. Chem. 16 2008 6207 6217 (Pubitemid 351758823)
131. C.W. Lee, R. Rivera, A.E. Dubin, and J. Chun LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation J. Biol. Chem. 282 2007 4310 4317 (Pubitemid 47100980)
132. K. Noguchi, S. Ishii, and T. Shimizu Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family J. Biol. Chem. 278 2003 25600 25606 (Pubitemid 36835313)
133. K. Yanagida, S. Ishii, F. Hamano, K. Noguchi, and T. Shimizu LPA4/p2y9/GPR23 mediates rho-dependent morphological changes in a rat neuronal cell line J. Biol. Chem. 282 2007 5814 5824 (Pubitemid 47093762)
134. K. Kotarsky, A. Boketoft, J. Bristulf, N.E. Nilsson, A. Norberg, S. Hansson, C. Owman, R. Sillard, L.M. Leeb-Lundberg, and B. Olde Lysophosphatidic acid binds to and activates GPR92, a G protein-coupled receptor highly expressed in gastrointestinal lymphocytes J. Pharmacol. Exp. Ther. 318 2006 619 628 (Pubitemid 44061237)
135. C.W. Lee, R. Rivera, S. Gardell, A.E. Dubin, and J. Chun GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5 J. Biol. Chem. 281 2006 23589 23597 (Pubitemid 44274133)
136. S.M. Pasternack, I. von Kugelgen, K.A. Aboud, Y.A. Lee, F. Ruschendorf, K. Voss, A.M. Hillmer, G.J. Molderings, T. Franz, A. Ramirez, P. Nurnberg, M.M. Nothen, and R.C. Betz G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth Nat. Genet. 40 2008 329 334 (Pubitemid 351311768)
137. N. Ancellin, and T. Hla Differential pharmacological properties and signal transduction of the sphingosine 1-phosphate receptors EDG-1, EDG-3, and EDG-5 J. Biol. Chem. 274 1999 18997 19002
138. V. Brinkmann Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology Pharmacol. Ther. 115 2007 84 105 (Pubitemid 46990553)
139. 2 + mobilization. Ras-mitogen-activated protein kinase activation, and adenylate cyclase inhibition J. Biol. Chem. 273 1998 27104 27110 (Pubitemid 28500416)
140. Y. Takuwa Subtype-specific differential regulation of Rho family G proteins and cell migration by the Edg family sphingosine-1-phosphate receptors Biochim. Biophys. Acta 1582 2002 112 120 (Pubitemid 34634119)
141. S. An, T. Bleu, W. Huang, O.G. Hallmark, S.R. Coughlin, and E.J. Goetzl Identification of cDNAs encoding two G protein-coupled receptors for lysosphingolipids FEBS Lett. 417 1997 279 282 (Pubitemid 27511604)
142. I. Ishii, B. Friedman, X. Ye, S. Kawamura, C. McGiffert, J.J. Contos, M.A. Kingsbury, G. Zhang, J.H. Brown, and J. Chun Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LP(B3)/EDG-3 J. Biol. Chem. 276 2001 33697 33704
143. M.H. Graler, G. Bernhardt, and M. Lipp EDG6, a novel G-protein-coupled receptor related to receptors for bioactive lysophospholipids, is specifically expressed in lymphoid tissue Genomics 53 1998 164 169 (Pubitemid 28496606)
144. M.H. Graler, R. Grosse, A. Kusch, E. Kremmer, T. Gudermann, and M. Lipp The sphingosine 1-phosphate receptor S1P4 regulates cell shape and motility via coupling to Gi and G12/13 J. Cell. Biochem. 89 2003 507 519 (Pubitemid 36648772)
145. D.S. Im, J. Clemens, T.L. Macdonald, and K.R. Lynch Characterization of the human and mouse sphingosine 1-phosphate receptor, S1P5 (Edg-8): structure-activity relationship of sphingosine1-phosphate receptors Biochemistry 40 2001 14053 14060 (Pubitemid 33078877)
146. C. Jaillard, S. Harrison, B. Stankoff, M.S. Aigrot, A.R. Calver, G. Duddy, F.S. Walsh, M.N. Pangalos, N. Arimura, K. Kaibuchi, B. Zalc, and C. Lubetzki Edg8/S1P5: an oligodendroglial receptor with dual function on process retraction and cell survival J. Neurosci. 25 2005 1459 1469 (Pubitemid 40250722)
147. A. Niedernberg, C.R. Scherer, A.E. Busch, and E. Kostenis Comparative analysis of human and rat S1P(5) (edg8): differential expression profiles and sensitivities to antagonists Biochem. Pharmacol. 64 2002 1243 1250 (Pubitemid 35257919)
148. R.A. Zoeller, P.D. Wightman, M.S. Anderson, and C.R. Raetz Accumulation of lysophosphatidylinositol in RAW 264.7 macrophage tumor cells stimulated by lipid A precursors J. Biol. Chem. 262 1987 17212 17220
149. D.M. Smith, and M. Waite Phosphatidylinositol hydrolysis by phospholipase A2 and C activities in human peripheral blood neutrophils J. Leukoc. Biol. 52 1992 670 678 (Pubitemid 23016042)
150. P. Francel, and G. Dawson Bradykinin induces the bi-phasic production of lysophosphatidyl inositol and diacylglycerol in a dorsal root ganglion X neurotumor hybrid cell line, F-11 Biochem. Biophys. Res. Commun. 152 1988 724 731
151. + channels Pflugers Arch. 462 2011 245 255
152. C.M. Henstridge, N.A. Balenga, R. Schroder, J.K. Kargl, W. Platzer, L. Martini, S. Arthur, J. Penman, J.L. Whistler, E. Kostenis, M. Waldhoer, and A.J. Irving GPR55 ligands promote receptor coupling to multiple signalling pathways Br. J. Pharmacol. 160 2010 604 614
153. A. Kapur, P. Zhao, H. Sharir, Y. Bai, M.G. Caron, L.S. Barak, and M.E. Abood Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands J. Biol. Chem. 284 2009 29817 29827